|
NL297170A
(enExample)
|
1963-04-04 |
1900-01-01 |
|
|
|
NL128365C
(enExample)
|
1963-11-05 |
|
|
|
|
US3449427A
(en)
*
|
1965-06-03 |
1969-06-10 |
Smithkline Corp |
Aminocyclopropane derivatives of 5h-dibenzo(a,d)cycloheptenes
|
|
US3697506A
(en)
*
|
1970-08-07 |
1972-10-10 |
Pfizer |
Crystalline alkali metal salts of {60 -carboxybenzylpenicillin and process therefor
|
|
US3686335A
(en)
*
|
1970-12-21 |
1972-08-22 |
Smith Kline French Lab |
5-vinyl-5h-di benzo(a,d)cycloheptenes
|
|
US4432987A
(en)
*
|
1982-04-23 |
1984-02-21 |
Pfizer Inc. |
Crystalline benzenesulfonate salts of sultamicillin
|
|
US4547505A
(en)
*
|
1983-03-25 |
1985-10-15 |
Degussa Aktiengesellschaft |
N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
|
|
CS244821B2
(en)
|
1983-06-16 |
1986-08-14 |
Boehringer Ingelheim Ltd |
Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas
|
|
DE3418167A1
(de)
|
1984-05-16 |
1985-11-21 |
Bayer Ag, 5090 Leverkusen |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen heteroaryloxyacetamiden
|
|
DE3600288A1
(de)
|
1986-01-08 |
1987-07-16 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonylharnstoff-derivaten
|
|
DE3618004A1
(de)
|
1986-05-28 |
1987-12-03 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonyliso(thio)-harnstoff-derivaten
|
|
CA2071897A1
(en)
|
1989-12-28 |
1991-06-29 |
Richard A. Glennon |
Sigma receptor ligands and the use thereof
|
|
CA2033390A1
(en)
*
|
1989-12-29 |
1991-06-30 |
Susumu Nakagawa |
2-(2-cyclopropylpyrrolidin-4-ylthio) carbapenem derivatives
|
|
BR9206396A
(pt)
|
1991-08-22 |
1994-12-13 |
Monsanto Co |
Pirazolilsulfoniluréias herbicidas de proteção
|
|
DE4131139A1
(de)
*
|
1991-09-19 |
1993-03-25 |
Bayer Ag |
Verfahren zur herstellung von 1-fluor-cyclopropan-1-carbonsaeure
|
|
KR100296810B1
(ko)
*
|
1993-03-12 |
2001-10-24 |
로렌스 티. 마이젠헬더 |
결정성세프티오퍼유리산
|
|
BR9509760A
(pt)
|
1994-11-23 |
1998-06-30 |
Neurogen Corp |
Composto
|
|
US5604253A
(en)
|
1995-05-22 |
1997-02-18 |
Merck Frosst Canada, Inc. |
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
|
|
US5859246A
(en)
|
1997-01-30 |
1999-01-12 |
Neurogen Corporation |
1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
|
|
EP0968200A1
(en)
|
1997-02-24 |
2000-01-05 |
ZymoGenetics, Inc. |
Calcitonin mimetics
|
|
US6160134A
(en)
|
1997-12-24 |
2000-12-12 |
Bristol-Myers Squibb Co. |
Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
|
|
WO1999037304A1
(en)
|
1998-01-27 |
1999-07-29 |
Aventis Pharmaceuticals Products Inc. |
SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
|
|
US6268367B1
(en)
|
1998-02-23 |
2001-07-31 |
Zymogenetics, Inc. |
Piperazine derivatives for treating bone deficit conditions
|
|
US6383520B1
(en)
*
|
1998-06-26 |
2002-05-07 |
Chugai Seiyaku Kabushiki Kaisha |
Fine powder of L-α-aminoadipic acid derivative, oral solid preparations containing the same, and method for treatment of bulk powders
|
|
WO2000040572A1
(en)
|
1999-01-08 |
2000-07-13 |
Neurogen Corporation |
1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands
|
|
US6284761B1
(en)
*
|
1999-01-08 |
2001-09-04 |
Neurogen Corporation |
1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands
|
|
GB9913083D0
(en)
*
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
|
US6936602B1
(en)
|
1999-06-16 |
2005-08-30 |
Takeda Chemical Industries, Ltd. |
Benzazepine derivatives, process for the preparation of the same and uses thereof
|
|
WO2001022963A1
(en)
|
1999-09-27 |
2001-04-05 |
Merck & Co., Inc. |
Method of preventing osteoporosis
|
|
NZ519984A
(en)
|
2000-01-07 |
2004-03-26 |
Transform Pharmaceuticals Inc |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
AU6872401A
(en)
|
2000-06-29 |
2002-01-14 |
Abbott Lab |
Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
|
US6521619B2
(en)
*
|
2000-06-29 |
2003-02-18 |
Icos Corporation |
Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
|
|
AU8066701A
(en)
|
2000-07-20 |
2002-02-05 |
Neurogen Corp |
Capsaicin receptor ligands
|
|
US6888012B2
(en)
|
2000-12-25 |
2005-05-03 |
Ajinomoto Co., Inc. |
Process for producing optically active halohydrin compound
|
|
EA005974B1
(ru)
*
|
2001-02-23 |
2005-08-25 |
Мерк Энд Ко., Инк. |
N-замещенные неарильные гетероциклические антагонисты nmda/nr2b
|
|
JP2005502623A
(ja)
|
2001-07-02 |
2005-01-27 |
ノボ ノルディスク アクティーゼルスカブ |
置換ピペラジンおよびジアゼパン
|
|
WO2003014110A1
(en)
|
2001-08-08 |
2003-02-20 |
Takeda Chemical Industries, Ltd. |
Benzazepine derivative, process for producing the same, and use
|
|
EP1442038A4
(en)
|
2001-09-26 |
2005-01-05 |
Merck & Co Inc |
CRYSTALLINE FORMS OF CARBAPENEM ANTIBIOTICS AND MANUFACTURING METHOD
|
|
US20050143372A1
(en)
*
|
2001-10-30 |
2005-06-30 |
Shomir Ghosh |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US6861432B2
(en)
*
|
2001-11-23 |
2005-03-01 |
Schering Aktiengesellschaft |
Piperazine derivatives that destabilize androgen receptors
|
|
BR0308525A
(pt)
*
|
2002-03-22 |
2005-02-01 |
Lg Life Sciences Ltd |
Formas cristalinas
|
|
WO2003103666A2
(en)
|
2002-06-07 |
2003-12-18 |
Altana Pharma Ag |
Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones
|
|
US20040209858A1
(en)
*
|
2002-10-22 |
2004-10-21 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
US20040077618A1
(en)
|
2002-10-22 |
2004-04-22 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
AU2003284402A1
(en)
|
2002-11-15 |
2004-06-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Antagonist to melanin-concentrating hormone receptor
|
|
ATE384724T1
(de)
|
2002-12-13 |
2008-02-15 |
Smithkline Beecham Corp |
Cyclopropylverbindungen als ccr5 antagonisten
|
|
DE602004015269D1
(de)
*
|
2003-04-23 |
2008-09-04 |
Glaxo Group Ltd |
Piperazin derivate und ihre verwendung für die behandlung von neurologischen und psychiatrischen krankheiten.
|
|
AU2004236240C1
(en)
|
2003-05-01 |
2010-11-04 |
Bristol-Myers Squibb Company |
Aryl-substituted pyrazole compounds useful as kinase inhibitors
|
|
AR045595A1
(es)
*
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
|
DE602004026629D1
(de)
|
2003-12-15 |
2010-05-27 |
Japan Tobacco Inc |
Cyclopropanderivate und ihre pharmazeutische verwendung
|
|
BRPI0418939A
(pt)
|
2004-07-06 |
2008-04-08 |
Xenon Pharmaceuticals Inc |
derivados de nicotinamida e sua utilização como agentes terapêuticos
|
|
TW200621760A
(en)
|
2004-09-09 |
2006-07-01 |
Mitsubishi Pharma Corp |
2-morpholino-4-pyrimidone compound
|
|
NZ554722A
(en)
|
2004-09-29 |
2010-07-30 |
Mitsubishi Tanabe Pharma Corp |
6-(Pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors
|
|
SI1802307T1
(sl)
|
2004-10-15 |
2008-08-31 |
Glaxo Group Ltd |
Derivati pirolidina kot ligandi histaminskih receptorjev
|
|
MX2007007220A
(es)
|
2004-12-27 |
2007-08-20 |
Astrazeneca Ab |
Compuestos de pirazolona como agonistas de receptor de glutamato metabotropico para el tratamiento de trastornos neurologicos y psiquiatricos.
|
|
EP1844052A1
(en)
*
|
2005-01-26 |
2007-10-17 |
Pharmacia & Upjohn Company LLC |
Thieno[2,3-d]pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
|
|
TW200640863A
(en)
*
|
2005-02-15 |
2006-12-01 |
Glaxo Group Ltd |
Compounds which potentiate glutamate receptor and uses thereof in medicine
|
|
EP2607362B1
(en)
|
2005-02-17 |
2014-12-31 |
Astellas Pharma Inc. |
Piperidine and piperazine carboxylates as FAAH inhibitors
|
|
JP2008534488A
(ja)
|
2005-03-25 |
2008-08-28 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
血小板凝集阻害剤としての４−ピペラジニルチエノ［２，３−ｄ］ピリミジン化合物
|
|
EP1896483A2
(en)
|
2005-03-28 |
2008-03-12 |
Pharmacia & Upjohn Company LLC |
4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
CA2602227A1
(en)
|
2005-03-28 |
2006-10-05 |
Michael Dalton Ennis |
4-piperazinylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
JP2008534573A
(ja)
|
2005-03-28 |
2008-08-28 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
血小板凝集阻害剤としての４−ピペラジノチエノ［２，３−ｄ］ピリミジン化合物
|
|
MX2008000745A
(es)
|
2005-07-15 |
2008-03-14 |
Schering Corp |
Derivados de quinazolina utiles en el tratamiento del cancer.
|
|
TW200740779A
(en)
*
|
2005-07-22 |
2007-11-01 |
Mitsubishi Pharma Corp |
Intermediate compound for synthesizing pharmaceutical agent and production method thereof
|
|
EP1909797A4
(en)
|
2005-08-02 |
2013-02-27 |
Neurogen Corp |
DIPIPERAZINYL KETONE AND RELATED ANALOG
|
|
UA96424C2
(ru)
*
|
2005-09-16 |
2011-11-10 |
Янссен Фармацевтика Н.В. |
Циклопропил амины как модуляторы н3 рецепторов гистамина
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
PT1951699E
(pt)
|
2005-10-31 |
2012-12-26 |
Janssen Pharmaceutica Nv |
Processos para a preparação de derivados de ciclopropilamida
|
|
CN101365686A
(zh)
|
2005-12-21 |
2009-02-11 |
沃泰克斯药物股份有限公司 |
作为离子通道调节剂的杂环衍生物
|
|
WO2007076140A2
(en)
|
2005-12-23 |
2007-07-05 |
University Of Cincinnati |
Treatment methods employing histamine h3 receptor antagonists, including betahistine
|
|
BRPI0707916A2
(pt)
*
|
2006-01-13 |
2011-05-17 |
Hoffmann La Roche |
compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem e uso destes compostos
|
|
CN101384581B
(zh)
|
2006-02-17 |
2013-09-18 |
弗·哈夫曼-拉罗切有限公司 |
作为5ht2/d3调节剂的苯甲酰基-哌啶衍生物
|
|
JP2009528240A
(ja)
|
2006-03-01 |
2009-08-06 |
セメンテク・ピーティーワイ・リミテッド |
メーソンリー部材用マトリックス及びその製造方法
|
|
JP2009132621A
(ja)
|
2006-03-13 |
2009-06-18 |
Ajinomoto Co Inc |
シクロプロピルアミド化合物の製造方法
|
|
AU2007231594A1
(en)
|
2006-03-23 |
2007-10-04 |
Amgen Inc. |
1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
|
|
WO2007138928A1
(ja)
|
2006-05-26 |
2007-12-06 |
Kaneka Corporation |
光学活性３－アミノ－２－ヒドロキシプロピオン酸シクロプロピルアミド誘導体およびその塩の製造方法
|
|
MX2008016343A
(es)
|
2006-06-23 |
2009-01-19 |
Abbott Lab |
Derivados ciclopropil amina como moduladores del receptro de histamina h3.
|
|
US9108948B2
(en)
*
|
2006-06-23 |
2015-08-18 |
Abbvie Inc. |
Cyclopropyl amine derivatives
|
|
WO2008003702A2
(en)
|
2006-07-03 |
2008-01-10 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Fused bicyclic compounds interacting with the histamine h4 receptor
|
|
GB0615620D0
(en)
*
|
2006-08-05 |
2006-09-13 |
Astrazeneca Ab |
A process for the preparation of optically active intermediates
|
|
EP2056828A4
(en)
|
2006-08-21 |
2010-06-23 |
Merck Sharp & Dohme |
SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS
|
|
TW200828371A
(en)
*
|
2006-09-21 |
2008-07-01 |
Matsushita Electric Industrial Co Ltd |
Chip-type filter
|
|
DE102006056526A1
(de)
|
2006-11-30 |
2008-06-05 |
Archimica Gmbh |
Verfahren zur stereoselektiven Synthese von chiralen Epoxiden durch ADH-Reduktion von alpha-Abgangsgruppen-substituierten Ketonen und Cyclisierung
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
WO2008147864A2
(en)
|
2007-05-22 |
2008-12-04 |
Xenon Pharmaceuticals Inc. |
Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
|
|
JP2010528007A
(ja)
|
2007-05-23 |
2010-08-19 |
メルク・シャープ・エンド・ドーム・コーポレイション |
シクロプロピルピロリジンオレキシン受容体アンタゴニスト
|
|
DE602008002598D1
(en)
|
2007-06-11 |
2010-10-28 |
Hoffmann La Roche |
Cyclohexylderivate
|
|
HRP20140047T1
(en)
*
|
2007-08-22 |
2014-02-14 |
Astrazeneca Ab |
Cycloptopyl amide derivatives
|
|
CN101815512B
(zh)
*
|
2007-10-04 |
2013-04-24 |
弗·哈夫曼-拉罗切有限公司 |
环丙基芳基酰胺衍生物和其用途
|
|
CL2009000004A1
(es)
|
2008-01-15 |
2010-02-19 |
Lilly Co Eli |
Forma cristalina de r-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida; composicion farmaceutica que comprende a dicha forma cristalina; y uso para el tratamiento de diabetes o hiperglicemia.
|
|
DE102008049371A1
(de)
|
2008-03-06 |
2009-09-10 |
Mühlbauer Ag |
Einrichtung mit einem RFID-Transponder in einem elektrisch leitfähigen Gegenstand und Herstellungsverfahren hierfür
|
|
KR20110005248A
(ko)
*
|
2008-03-20 |
2011-01-17 |
포레스트 래보러토리즈 홀딩스 리미티드 |
스테아로일-ｃｏａ 탈포화효소의 억제제로서의 신규한 피페라진 유도체
|
|
EP2300422B1
(en)
*
|
2008-05-08 |
2014-11-05 |
Evotec AG |
Azetidines as histamine h3 receptor antagonists
|
|
US8586607B2
(en)
|
2008-07-28 |
2013-11-19 |
Syddansk Universitet |
Compounds for the treatment of metabolic diseases
|
|
CN101462980B
(zh)
|
2009-01-05 |
2013-01-09 |
扬州天辰精细化工有限公司 |
2，6—二氟苯甲酰胺的工业化生产方法
|
|
TW201039825A
(en)
*
|
2009-02-20 |
2010-11-16 |
Astrazeneca Ab |
Cyclopropyl amide derivatives 983
|
|
US20110201622A1
(en)
|
2010-02-18 |
2011-08-18 |
Collins Craig D |
Solid Forms Comprising A Cyclopropyl Amide Derivative
|
|
BR112012020629A2
(pt)
*
|
2010-02-18 |
2018-06-19 |
Astrazeneca Ab |
forma cristalina, e, método para a terapia de um distúrbio
|